skip to Main Content


Canntab Therapeutics gets first commercial sale with Medipharm!

Watch our soon to be Executive Chairman, Larry Latowsky, talk at Cannacord Genuity’s May 2020 Cannabis Conference!

We’ve Received our Cannabis Licence for Processing and Medical Sales!

Canntab Therapeutics granted cannabis Research Licence from Health Canada

Canntab Therapeutics sign supply and distribution agreement with Exactus in the US.

Our CFO, Richard Goldstein was on The Midas Letter yesterday, discussing our latest deal with World Class Extractions.

Did you miss The Midas Letter yesterday? Our Co-Founder and CFO, Richard Goldstein was on the show talking about the patentability of our instant release formulation.

Richard Goldstein, our CFO, was on Proactive Investor with Steve Darling talking about the patentability of our Instant Release formulation. Check out the full vid here

Our Co-Founders, Jeff Renwick and Richard Goldstein, were at the LD Micro Conference in Bel Air, California. Take a look at this interview they did with @proactive_ca

Our Co-Founder and CFO Richard Goldstein was on @proactive_ca with @clintsharples of @HeritageCann talking about their recently announced partnership.

Check out this Richmond Club interview with our Director of Marketing, Eric Malinski, discussing the future of Canntab in 2019 and beyond!

Our co-founder and CFO, Richard Goldstein was on Proactive Investors, talking about our new Industrial Hemp licence from Health Canada!

Our CFO Richard Goldstein was a guest on @MidasLetter with James West. Check out the video as they discuss our new hemp supply deal!


Interested in what we do? Want to learn more about the opportunities we offer? Get in touch, enter your information and ask any questions you may have. We'll be sure to respond as soon as possible.

You can also reach us at


This presentation contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, or “will be taken”, “occur”, or “be achieved”. Forward-looking information is based on the opinions and estimates of management at the date the information is made, and is based on a number of assumptions and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including risks related to market and financing conditions as well as risks associated with the industries in which the Company operates, changes in project parameters as plans continue to be refined as well as other risk factors.  Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information contained herein.

Back To Top